Key facts
- The Trump administration canceled federal grants for Alzheimer's research.
- Emory University and the University of Pittsburgh are affected by the grant cancellations.
- The canceled grants were for studies on the impacts of racism and discrimination.
- Researchers state that racism and discrimination are scientifically valid concepts.
- The cancellations appear to be linked to concerns about diversity, equity, and inclusion (DEI).
- Millions of dollars in funding have been canceled.
The Trump administration has halted millions of dollars in federal funding for Alzheimer's disease research at two prominent universities: Emory University and the University of Pittsburgh. These cancellations specifically target research projects that examine the effects of racism and discrimination on Alzheimer's disease. Researchers involved in these studies assert that the impacts of racism and discrimination are scientifically valid and critical components for understanding the disease's progression, especially in diverse communities. The administration's decision has sparked debate regarding the role of diversity, equity, and inclusion (DEI) principles in the allocation of scientific research grants. Critics argue that the cancellations represent a politically motivated interference in scientific inquiry, potentially hindering progress in understanding a complex disease that disproportionately affects certain demographic groups. The exact amount of funding canceled has not been specified, but it is described as 'millions of dollars.' The administration has not publicly detailed the specific reasons for the cancellations beyond general concerns related to DEI, leading to speculation that these studies are being singled out due to their focus on social determinants of health and systemic inequities.